Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

NCT00001228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Islet Cell Adenoma
Zollinger Ellison Syndrome

Interventions

DRUG: Interferon

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)